Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Loargys 5 mg/ml solution for injection/infusion {equilateral_black_triangle}

Active Ingredient:
pegzilarginase
Company:  
Immedica See contact details
ATC code: 
A16AB24
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Loargys

IMPORTANT INFORMATION ON MINIMISING THE RISK OF HYPERSENSITIVITY REACTIONS AND MEDICATION ERRORS FOLLOWING SELF ADMINISTRATION AT HOME.

Together with your doctor, it has been decided that you or a caregiver will carry out the injection of Loargys (pegzilarginase) yourselves at home. This guide supplements the information in the package leaflet and the information provided by your treating doctor. This guide aims to inform you about:

• the importance of proper handling

• preparation and administration of pegzilarginase to reduce the risk of medication errors

• the risk of Allergic (hypersensitivity) reactions

• how to report side effects

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Immedica
Company image
Address
The Townhouse, 114-116 Fore Street, Hertford,, Herts, SG14 1AJ, UK
WWW
http://www.immedica.com
Telephone
+46 (0)8 533 39 500
Medical Information Direct Line
+46 (0)8 533 39 500
Medical Information e-mail
[email protected]